Suppr超能文献

患者对口服抗凝治疗及其对生活质量影响的认知。

Patients' perceptions regarding oral anticoagulation therapy and its effect on quality of life.

作者信息

Casais P, Meschengieser S S, Sanchez-Luceros A, Lazzari M A

机构信息

Thrombosis and Hemostasis Department, Institute of Haematological Research, National Academy of Medicine, Buenos Aires, Argentina.

出版信息

Curr Med Res Opin. 2005 Jul;21(7):1085-90. doi: 10.1185/030079905X50624.

Abstract

OBJECTIVE

Anticoagulation clinics have improved the time spent within therapeutic range and decreased hemorrhagic complications and costs in chronic oral anticoagulation. Whether these benefits correlate to patients' quality of life (QOL) remains to be determined. The impact of patients' perceptions about anticoagulation on QOL has not been evaluated. The objective of this study was to evaluate prospectively patients' perceptions and quality of life in patients chronically anticoagulated.

RESEARCH DESIGN AND METHODS

A cross-sectional study was designed to investigate the prevalence of positive and negative perceptions about oral anticoagulation therapy (OAT) and to identify vulnerable groups. Patients anonymously completed the SF-36 survey and a questionnaire that focused on patients' perceptions of protection from thrombotic complications or fear of haemorrhage due to the anticoagulation. We related those perceptions to the General Health SF-36 score, to the patient's characteristics, the absolute bleeding risk (i.e. intended International Normalized Ratio [INR]), duration of therapy and medical attention.

RESULTS

One thousand patients were included and 905 questionnaires evaluated. Most patients felt protected and better since the beginning of therapy (71.5% and 61.5%, respectively). Patient characteristics associated with negative perceptions were; female sex (Odds Ratio [OR] 1.58, 95% Confidence Interval [CI] 1.06-2.36, p = 0.01); patients with less than 1 year of therapy (OR 2.16, 95% CI 1.34-3.48, p = 0.006); those not satisfied with medical attention (OR 2.86, 95% CI 1.53-5.18, p = 0.0001); and those that modified their lifestyle (OR 2.75, 95% CI 1.49-4.91, p = 0.0002). Patients with a lower bleeding risk (INR 2.0-3.0) had more negative perceptions than those with a higher risk. Patients with negative perceptions achieved the lowest score in the SF-36 survey. Haemorrhages did not affect patients' perception or QOL.

CONCLUSIONS

Patients' perceptions correlated with QOL. We were able to identify patient characteristics associated with poor QOL and thus the group of patients whose negative perceptions most warranted special attention from their clinicians.

摘要

目的

抗凝门诊已改善了慢性口服抗凝治疗中处于治疗范围内的时间,并降低了出血并发症和成本。这些益处是否与患者的生活质量(QOL)相关仍有待确定。患者对抗凝治疗的看法对生活质量的影响尚未得到评估。本研究的目的是前瞻性地评估长期接受抗凝治疗患者的看法和生活质量。

研究设计与方法

一项横断面研究旨在调查对口服抗凝治疗(OAT)的积极和消极看法的患病率,并确定弱势群体。患者匿名完成SF - 36调查问卷以及一份侧重于患者对预防血栓形成并发症的看法或因抗凝治疗而对出血的恐惧的问卷。我们将这些看法与SF - 36总体健康评分、患者特征、绝对出血风险(即预期国际标准化比值[INR])、治疗持续时间和医疗护理相关联。

结果

纳入1000例患者,评估了905份问卷。大多数患者自治疗开始以来感觉受到了保护且状况有所改善(分别为71.5%和61.5%)。与负面看法相关的患者特征包括:女性(比值比[OR] 1.58,95%置信区间[CI] 1.06 - 2.36,p = 0.01);治疗时间少于1年的患者(OR 2.16,95% CI 1.34 - 3.48,p = 0.006);对医疗护理不满意的患者(OR 2.86,95% CI 1.53 - 5.18,p = 0.0001);以及改变生活方式的患者(OR 2.75,95% CI 1.49 - 4.91,p = 0.0002)。出血风险较低(INR 2.0 - 3.0)的患者比风险较高的患者有更多负面看法。有负面看法的患者在SF - 36调查中得分最低。出血并未影响患者的看法或生活质量。

结论

患者的看法与生活质量相关。我们能够识别与生活质量差相关的患者特征,从而确定其负面看法最值得临床医生特别关注的患者群体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验